Mutagenicity studies with N-acetyl-l-aspartic acid

Food and Chemical Toxicology

Volumn 47, Issue 8, 2009, Pages 1936-1940

  Karaman, Sule ^a   Myhre, Abby ^b   Maria Donner, E ^b   Munley, Susan M ^b   Delaney, Bryan ^a  

^a A DuPont Company   (United States)

^b DUPONT COMPANY   (United States)

Author keywords

Bacterial mutagenicity; Bone marrow micronucleus assay; Genetic toxicity; l Aspartate; N acetyl l aspartate

Indexed keywords

AMINO ACID; ASPARTIC ACID; N ACETYLASPARTIC ACID;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIUM CULTURE; BONE MARROW CELL; CONTROLLED STUDY; FEMALE; GENOTOXICITY; IN VIVO STUDY; MALE; MAMMAL; MICRONUCLEUS TEST; MOUSE; MUTAGEN TESTING; NONHUMAN; POINT MUTATION; TOXICITY TESTING;

ANIMALS; ASPARTIC ACID; BONE MARROW; ESCHERICHIA COLI; MICE; MICE, INBRED ICR; MICRONUCLEUS TESTS; MUTAGENICITY TESTS; MUTAGENS; SALMONELLA TYPHIMURIUM;

ANIMALIA; BACTERIA (MICROORGANISMS); MAMMALIA;

EID: 68649087592     PISSN: 02786915     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fct.2009.05.005     Document Type: Article

References (24)

1. Barale R., Micheletti R., Sbrana C., Glussich I., Scapoli C., and Barrai I. N-acetylcysteine inhibits diesel extract mutagenicity in the Ames test and SCE induction in human lymphocytes. Basic Life Sci. 61 (1993) 149-160
2. Baslow MH. N-acetylaspartate in the vertebrate brain: metabolism and function. Neurochem. Res. 28 6 (2003) 941-953
3. Berger U.V., Luthi-Carter R., Pasani L.A., Elkabes S., Black I., Konradi C., and Coyle J.T. Glutamate carboxypeptidase II is expressed by astrocytes in the adult rat nervous system. J. Comp. Neurol. 415 1 (1999) 52-64
4. Bhakoo K.K., Craig T., and Pearce D. N-acetylaspartate metabolism in neural cells. In: Moffett J.R., Tieman S.B., Weinberger D.R., Coyle J.T., and Namboodiri A.M.A. (Eds). N-acetyl Aspartate: A Unique Neuronal Molecule in the Central Nervous System. First International Symposium on N-acetylaspartate, 2004, Bethesda, Maryland. Advances in Experimental Medicine and Biology 576 (2006), Springer Science and Business Media, Inc., New York 27-47 (discussion 361-363)
5. Bonanomi L., and Gazzaniga A. Toxicological, pharmacokinetic and metabolic studies on acetylcysteine. Eur. J. Respir. Dis. Suppl. 111 (1980) 45-51
6. Chakraborty G., Mekala P., Yahya D., Wu G., and Ledeen R.W. Intraneuronal N-acetylaspartate supplies acetyl groups for myelin lipid synthesis: evidence for myelin-associated aspartoacylase. J. Neurochem. 78 4 (2001) 736-745
7. D'Adamo Jr. A.F., Smith J.C., and Woiler C. The occurrence of N-acetylaspartate amidohydrolase (aminoacylase II) in the developing rat. J. Neurochem. 20 4 (1973) 1275-1278
8. Glatt H. Endogenous mutagens derived from amino acids. Mutat. Res. 238 3 (1990) 235-243
9. Harris K., Lin A., Bhattacharya P., Tran T., Wong W., and Ross B. Regulation of NAA-synthesis n the human brain in vivo: Canavan's disease, Alzheimer's disease, and Schizophrenia. In: Moffett J.R., Tieman S.B., Weinberger D.R., Coyle J.T., and Namboodiri A.M.A. (Eds). N-acetylaspartate - A Unique Neuronal Molecule in the Central Nervous System (2006), Springer, New York, NY 263-273
10. Hession A., Esrey E., Croes R., and Maxwell C. N-acetylaspartate and N-acetylglutamate in Soybeans (Glycine max (L.) Merr.), Maize (Zea maize L.) and other foodstuffs. J. Agric. Food Chem. 56 19 (2008) 9121-9126
11. Kaul R., Gao G.P., Balamurugan K., and Matalon R. Cloning of the human aspartoacylase cDNA and a common missense mutation in Canavan disease. Nature Genet. 5 2 (1993) 118-123
12. Kaul R., Gao G.P., Matalon R., Aloya M., Su Q., Jin M., Johnson A.B., Schutgens R.B., and Clarke J.T. Identification and expression of eight novel mutations among non-Jewish patients with Canavan disease. Am. J. Hum. Genet. 59 1 (1996) 95-102
13. Kirmani B.F., Jacobowitz D.M., Kallarakal A.T., and Namboodiri M.A. Aspartoacylase is restricted primarily to myelin synthesizing cells in the CNS: therapeutic implications for Canavan disease. Brain Res. Mol. Brain Res. 107 2 (2002) 176-182
14. Kumar S., Mattan N.S., and de Vellis J. Canavan disease: a white matter disorder. Ment. Retard. Dev. Disabil. Res. Rev. 12 2 (2006) 157-165
15. Ledeen R.W., Wang J., Wu G., Lu Z.-H., Chakraborty G., Meyenhoffer M., Tryring S.K., and Matalon R. Physiological role of N-acetylaspartate. Contribution to myelinogenesis. In: Moffett J.R., Tieman S.B., Weinberger D.R., Coyle J.T., and Namboodiri A.M.A. (Eds). N-acetylaspartate: A Unique Neuronal Molecule in the Central Nervous System. First International Symposium on N-acetylaspartate, 2004, Bethesda, Maryland. Adv. Exp. Med. Biol. 576 (2006), Springer Science and Business Media, Inc., New York 131-143
16. Lieberman E.M., Achreja M., and Urazaev A.K. Synthesis of N-acetylaspartyl-glutamate (NAAG) and N-acetylaspartate (NAA) in axons and glia of the crayfish medial giant nerve fiber. Adv. Exp. Med. Biol. 576 (2006) 303-315 (discussion 361-363)
17. Lu Z.H., Chakraborty G., Ledeen R.W., Yahya D., and Wu G. N-acetylaspartate synthase is bimodally expressed in microsomes and mitochondria of brain. Brain Res. Mol. Brain Res. 122 (2004) 71-78
18. Miyake M., Kakimoto Y., and Sorimachi M. A gas chromatographic method for the determination of N-acetyl-l-aspartic acid, N-acetyl-alpha-aspartylglutamic acid and beta-citryl-l-glutamic acid and their distributions in the brain and other organs of various species of animals. J. Neurochem. 36 3 (1981) 804-810
19. Moffett J.R., Ross B., Arun P., Madhavarao C.N., and Namboodiri A.M. N-acetylaspartate in the CNS: from neurodiagnostics to neurobiology. Prog. Neurobiol. 81 2 (2007) 89-131
20. OECD, 1998a. OECD guideline for testing of chemicals. 471. Bacterial reverse mutation test. Ninth Addendum to the OECD Guidelines for the Testing of Chemicals. OECD, Paris, February 1998.
21. OECD, 1998b. Guideline for testing of chemicals. 474. Mammalian erythrocyte micronucleus test. Ninth Addendum to the OECD Guidelines for the Testing of Chemicals. OECD, Paris, February 1998.
22. Tallan H.H., Moore S., and Stein W.H. N-acetyl-l-aspartic acid in brain. J. Biol. Chem. 219 1 (1956) 257-264
23. Tsai G., and Coyle J.T. N-acetylaspartate in neuropsychiatric disorders. Prog. Neurobiol. 46 5 (1995) 531-540
24. Wilpart M., Mainguet P., Geeroms D., and Roberfroid M. Desmutagenic effects of N-acetylcysteine on direct and indirect mutagens. Mutat. Res. 142 4 (1985) 169-177